Literature DB >> 9376449

Alterations in the cortical serotonergic system in schizophrenia: a postmortem study.

E V Gurevich1, J N Joyce.   

Abstract

Previous studies have suggested a disturbance in the cortical serotonergic (5-HT) system in schizophrenia; however, these studies have been confounded by suicide in the patients groups, which in itself is associated with alterations in the 5-HT system. In this study we characterized various components of the 5-HT system in 14 areas of the frontal and parietal cortex in tissue obtained at postmortem from aged chronically hospitalized nonsuicidal schizophrenics compared to age-matched controls. We found no differences between control and schizophrenic subjects in the density of 5-HT uptake sites or other markers of 5-HT innervation. In Brodmann areas 24 and 6 the concentration of 5-HT2A,C receptors was decreased in all schizophrenics regardless of their antipsychotic treatment history. In all other areas examined 5-HT2A,C receptor concentrations were dramatically decreased in schizophrenics patients on drugs at time of death, whereas those off drugs at death showed the same values as control subjects. The density of 5-HT1A receptors was increased in areas 24, 9a (caudal part of area 9), 44, and 6 in subjects with schizophrenia. Antipsychotic treatment did not appear to have a significant effect. Thus, the specific pattern of alterations in the 5-HT system in schizophrenia may depend on the patient population and on antemortem antipsychotic treatment. These data also provide evidence that regulation of the 5-HT2 receptor may be involved in antipsychotic action.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9376449     DOI: 10.1016/S0006-3223(97)00321-1

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  23 in total

Review 1.  Regulation of GABAergic inhibition by serotonin signaling in prefrontal cortex: molecular mechanisms and functional implications.

Authors:  Zhen Yan
Journal:  Mol Neurobiol       Date:  2002 Oct-Dec       Impact factor: 5.590

2.  Selective serotonin 5-HT2A receptor antagonist EMD 281014 improves delayed matching performance in young and aged rhesus monkeys.

Authors:  Alvin V Terry; Jerry J Buccafusco; Gerd D Bartoszyk
Journal:  Psychopharmacology (Berl)       Date:  2004-12-24       Impact factor: 4.530

Review 3.  Therapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinson's disease.

Authors:  Yukihiro Ohno
Journal:  CNS Neurosci Ther       Date:  2010-11-21       Impact factor: 5.243

4.  The effect of a serotonin-induced dissociation between spiking and perisynaptic activity on BOLD functional MRI.

Authors:  Alexander Rauch; Gregor Rainer; Nikos K Logothetis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-05-02       Impact factor: 11.205

5.  Prevention of the phencyclidine-induced impairment in novel object recognition in female rats by co-administration of lurasidone or tandospirone, a 5-HT(1A) partial agonist.

Authors:  Masakuni Horiguchi; Kayleen E Hannaway; Adesewa E Adelekun; Karu Jayathilake; Herbert Y Meltzer
Journal:  Neuropsychopharmacology       Date:  2012-06-27       Impact factor: 7.853

6.  Activity-dependent bidirectional regulation of GABA(A) receptor channels by the 5-HT(4) receptor-mediated signalling in rat prefrontal cortical pyramidal neurons.

Authors:  Xiang Cai; Jorge Flores-Hernandez; Jian Feng; Zhen Yan
Journal:  J Physiol       Date:  2002-05-01       Impact factor: 5.182

Review 7.  Epigenetic Mechanisms of Serotonin Signaling.

Authors:  Terrell Holloway; Javier González-Maeso
Journal:  ACS Chem Neurosci       Date:  2015-03-10       Impact factor: 4.418

8.  Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors.

Authors:  Taku Nagai; Rina Murai; Kanae Matsui; Hiroyuki Kamei; Yukihiro Noda; Hiroshi Furukawa; Toshitaka Nabeshima
Journal:  Psychopharmacology (Berl)       Date:  2008-08-06       Impact factor: 4.530

9.  Identification of a serotonin/glutamate receptor complex implicated in psychosis.

Authors:  Javier González-Maeso; Rosalind L Ang; Tony Yuen; Pokman Chan; Noelia V Weisstaub; Juan F López-Giménez; Mingming Zhou; Yuuya Okawa; Luis F Callado; Graeme Milligan; Jay A Gingrich; Marta Filizola; J Javier Meana; Stuart C Sealfon
Journal:  Nature       Date:  2008-02-24       Impact factor: 49.962

10.  HTR2A A-1438G/T102C polymorphisms predict negative symptoms performance upon aripiprazole treatment in schizophrenic patients.

Authors:  Shih-Fen Chen; Yu-Chih Shen; Chia-Hsiang Chen
Journal:  Psychopharmacology (Berl)       Date:  2009-04-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.